SaltX Technology Holding B Logo

SaltX Technology Holding B

Develops electric calcination tech to decarbonize heavy industries like cement and capture CO2.

SALT | ST

Overview

Corporate Details

ISIN(s):
SE0005308541 (+1 more)
LEI:
549300W31010S0FY9U64
Country:
Sweden
Address:
Västertorpsvägen 135, 129 44 Hägersten
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

SaltX Technology is a greentech company dedicated to decarbonizing heavy industries and eliminating their dependency on fossil fuels. The company innovates and industrializes electrification and carbon separation technologies targeting hard-to-abate sectors like cement and quicklime. Its core technology is the Electric Arc Calciner (EAC), a proprietary electric calcination process that replaces fossil-fuel heating. The EAC technology simultaneously separates and captures process-related CO2 emissions, creating a pathway to zero-emission manufacturing. SaltX collaborates with major industrial partners, such as Holcim and SMA Mineral, to scale its solutions and achieve gigaton-level impact on global emissions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all SaltX Technology Holding B filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SaltX Technology Holding B

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SaltX Technology Holding B via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Stayble Therapeutics AB Logo
Develops an injectable drug for lumbar disc herniation pain as an alternative to surgery.
Sweden
STABL
STCUBE Logo
Develops first-in-class immunotherapies targeting BTN1A1 for treatment-resistant cancers.
South Korea
052020
StemRIM Inc. Logo
Developing regenerative medicines that use the body's own stem cells to treat intractable diseases.
Japan
4599
Surrozen, Inc./DE Logo
Develops regenerative antibodies modulating the Wnt pathway to repair tissues and restore organs.
United States of America
SRZN
SyntekaBio,Inc. Logo
AI drug discovery platform accelerating R&D with supercomputing, SaaS, and pre-made candidates.
South Korea
226330
Tango Therapeutics, Inc. Logo
Developing precision oncology therapies for genetically-defined patients via synthetic lethality.
United States of America
TNGX
Taysha Gene Therapies, Inc. Logo
Developing AAV-based gene therapies for rare, severe monogenic diseases of the central nervous system.
United States of America
TSHA
Tectonic Therapeutic, Inc. Logo
Developing biologic therapies that modulate GPCRs for diseases with unmet needs.
United States of America
TECX
Telomir Pharmaceuticals, Inc. Logo
Developing an oral small molecule to reverse aging and treat age-related diseases.
United States of America
TELO
Tempest Therapeutics, Inc. Logo
Clinical-stage oncology company developing oral small molecule therapeutics to treat cancer.
United States of America
TPST

Talk to a Data Expert

Have a question? We'll get back to you promptly.